ESC 365 - Systemic microvascular dysfunction in heart failure with preserved ejection fraction: the PROSE-HFpEF case-control study

Open Access

Systemic microvascular dysfunction in heart failure with preserved ejection fraction: the PROSE-HFpEF case-control study

Session: Heart failure in the era of precision medicine: insights into pathophysiology and emerging treatments

Topic: Heart Failure with Preserved Ejection Fraction (HFpEF)

Speaker: Doctor J. Weerts (Maastricht, NL)

Event: Heart Failure 2025

Congress Presentation

Add to my library

About the speaker

Doctor Jerremy Weerts

Maastricht University Medical Center+, Maastricht (Netherlands (The))

0 follower

6 more presentations in this session

Body mass related epigenetic reprogramming and downstream analysis in heart failure phenotypes

Speaker: Miss E. Yapici (Mainz, DE)

Long COVID: insights from echocardiography, cardiac magnetic resonance, and endomyocardial Biopsies in previous healthy individuals with persistent chest pain

Speaker: Doctor O. Gomez Monterrosas (Puebla, MX)

A characterisation of mitochondrial structure, oxidative phosphorylation capacity, and amyloid burden in patients with wild-type transthyretin cardiomyopathy

Speaker: Doctor B. Ladefoged (Aarhus, DK)

Beneficial metabolic effects of 2-week ketone ester in patients with type 2 diabetes and heart failure with preserved ejection fraction.

Speaker: Doctor N. Gopalasingam (Aarhus, DK)

The effect of spironolactone on infections in heart failure with preserved ejection fraction

Speaker: Doctor B. Szabo-Soderberg (Orebro, SE)

Access the full session

Heart failure in the era of precision medicine: insights into pathophysiology and emerging treatments

Speakers: Doctor J. Weerts, Miss E. Yapici, Doctor O. Gomez Monterrosas, Doctor B. Ladefoged, Doctor N. Gopalasingam...

About the event

Heart Failure 2025

17 May - 20 May 2025

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources

Explore sponsored resources

Explore sponsored resources